Learn about and participate in local and national clinical trials.


Phase 3, Double-blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-Binary Individuals who have Sex with Men ≥ 16 years of Age who have sex with Male Partners and are at Risk for HIV Infection

Currently Enrolling? Yes, Contact Darmani Paramore at [email protected] or call 202-970-6787. link isn’t active yet. They’re still finalizing the protocol.

Title: Phase 1 Study to Evaluate the Safety of Genetically Modified, Autologous T Cells in Participants with HIV that is Well-Controlled on Antiretroviral Therapy

Currently Enrolling? NO.

Title: GS-US-544-5905-02 – An Umbrella Phase 1b, Open-label, Multi-Cohort Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Novel Antiretroviral in Participants With HIV-1

Currently Enrolling? YES. Contact Nino Guillen at [email protected] or call 202-970-6758 for more information.

For more information on this project, visit

Title:  A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination with Lenacapavir in Virologically Suppressed People with HIV

Currently Enrolling? Yes. Contact Darmani Paramore at [email protected] or call 202-970-6787  for more information.

For more information on this project, visit

The DC Cohort is a longitudinal research project that will collect clinical data from approximately 10,000 consenting HIV-infected outpatients receiving care at fifteen large treatment clinics in the District of Columbia. The DC Cohort is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).

The primary project goal is to improve the quality of care and treatment of HIV-infected patients at large clinics in the District of Columbia by:

  • Linking data from fifteen large treatment clinics to enable evaluation of HIV/AIDS care provided in the District of Columbia
  • Monitoring socio-demographic data, clinical status and treatment regimens of HIV-infected patients in DC over time
  • Providing clinic sites with routine reports on their patient population that will enable them to benchmark and improve their standards of clinical care
  • Contributing to the research of emerging issues in the prevention, treatment, and long-term effects of HIV/AIDS-infected persons.
  • Evaluating the impact of HIV screening and prevention programs in collaboration with the DC Department of Health

The project’s scientific objectives are to contribute to the knowledge regarding HIV-infected patients and their treatment through:

  • Evaluating the outcomes of HIV treatment regimens over time
  • Examining resistance patterns over time in relation to treatment patterns and patient characteristics
  • Assessing the extent and impact of co-morbidities, such as hepatitis, diabetes, lipidemia and STDs, on clinical outcomes
  • Advancing research on emerging issues in HIV and its treatment

Currently Enrolling? Yes, we are enrolling new patients.

For more information on this project, visit D.C. Cohort Longitudinal HIV Study.

Title: Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor in Combination with an Optimized Background Regimen in Heavily Treatment Experienced People Living with HIV-1 Infection with Multidrug Resistance

Currently Enrolling? No.

For more information on this project, visit



Learn more about the services we provide.



Support our mission to improve community health.